Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

A. Pecora; M. S.Perez Aguirreburualde; D. Rodriguez; C. Seki; M. S. Levy; D. Bochoeyer; M. J. Dus Santos; A. Wigdorovitz

doi:10.1016/j.jviromet.2009.07.031

Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

A. Pecora, M. S.Perez Aguirreburualde, D. Rodriguez, C. Seki, M. S. Levy, D. Bochoeyer, M. J. Dus Santos, A. Wigdorovitz

Veterinary Population Medicine

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.

Original language	English (US)
Pages (from-to)	170-178
Number of pages	9
Journal	Journal of Virological Methods
Volume	162
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jviromet.2009.07.031
State	Published - Jan 2009

Bibliographical note

Funding Information:
This work was financially supported by Biogénesis-Bagó S.A. Argentina. The authors want to thank Ayelén Sammarruco for technical laboratory assistance and to INTA's Adventicious Virus Laboratory, Herpesvirus Laboratory and Gastroenteric Virus Laboratory for their collaboration in the inter-laboratory trial. The authors are especially grateful to Dr. Viviana Parreño (INTA) for her collaboration in cattle experiments, to Lucia Makek (INTA) for her help in statistical analysis and to Tarit K. Mukhopadhyay (University College London) for his help in editing.

Keywords

BVDV
ELISA
Validation

Access

10.1016/j.jviromet.2009.07.031

Fingerprint Dive into the research topics of 'Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production'. Together they form a unique fingerprint.

Cite this

Pecora, A., Aguirreburualde, M. S. P., Rodriguez, D., Seki, C., Levy, M. S., Bochoeyer, D., Dus Santos, M. J., & Wigdorovitz, A. (2009). Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production. Journal of Virological Methods, 162(1-2), 170-178. https://doi.org/10.1016/j.jviromet.2009.07.031

Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production. / Pecora, A.; Aguirreburualde, M. S.Perez; Rodriguez, D.; Seki, C.; Levy, M. S.; Bochoeyer, D.; Dus Santos, M. J.; Wigdorovitz, A.

In: Journal of Virological Methods, Vol. 162, No. 1-2, 01.2009, p. 170-178.

Research output: Contribution to journal › Article › peer-review

Pecora, A, Aguirreburualde, MSP, Rodriguez, D, Seki, C, Levy, MS, Bochoeyer, D, Dus Santos, MJ & Wigdorovitz, A 2009, 'Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production', Journal of Virological Methods, vol. 162, no. 1-2, pp. 170-178. https://doi.org/10.1016/j.jviromet.2009.07.031

@article{061b559c051b461687762462ba01616b,

title = "Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production",

abstract = "Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.",

keywords = "BVDV, ELISA, Validation",

author = "A. Pecora and Aguirreburualde, {M. S.Perez} and D. Rodriguez and C. Seki and Levy, {M. S.} and D. Bochoeyer and {Dus Santos}, {M. J.} and A. Wigdorovitz",

note = "Funding Information: This work was financially supported by Biog{\'e}nesis-Bag{\'o} S.A. Argentina. The authors want to thank Ayel{\'e}n Sammarruco for technical laboratory assistance and to INTA's Adventicious Virus Laboratory, Herpesvirus Laboratory and Gastroenteric Virus Laboratory for their collaboration in the inter-laboratory trial. The authors are especially grateful to Dr. Viviana Parre{\~n}o (INTA) for her collaboration in cattle experiments, to Lucia Makek (INTA) for her help in statistical analysis and to Tarit K. Mukhopadhyay (University College London) for his help in editing.",

year = "2009",

month = jan,

doi = "10.1016/j.jviromet.2009.07.031",

language = "English (US)",

volume = "162",

pages = "170--178",

journal = "Journal of Virological Methods",

issn = "0166-0934",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

AU - Pecora, A.

AU - Aguirreburualde, M. S.Perez

AU - Rodriguez, D.

AU - Seki, C.

AU - Levy, M. S.

AU - Bochoeyer, D.

AU - Dus Santos, M. J.

AU - Wigdorovitz, A.

N1 - Funding Information: This work was financially supported by Biogénesis-Bagó S.A. Argentina. The authors want to thank Ayelén Sammarruco for technical laboratory assistance and to INTA's Adventicious Virus Laboratory, Herpesvirus Laboratory and Gastroenteric Virus Laboratory for their collaboration in the inter-laboratory trial. The authors are especially grateful to Dr. Viviana Parreño (INTA) for her collaboration in cattle experiments, to Lucia Makek (INTA) for her help in statistical analysis and to Tarit K. Mukhopadhyay (University College London) for his help in editing.

PY - 2009/1

Y1 - 2009/1

N2 - Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.

AB - Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.

KW - BVDV

KW - ELISA

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=70349746737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349746737&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2009.07.031

DO - 10.1016/j.jviromet.2009.07.031

M3 - Article

C2 - 19665482

AN - SCOPUS:70349746737

VL - 162

SP - 170

EP - 178

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

IS - 1-2

ER -

Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

Abstract

Bibliographical note

Keywords

Access

Other files and links

Cite this